Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating immunobullous diseases: an update.

Sandrine Reynaert1, Martin M Black

  • 1St. John's Institute of Dermatology, St. Thomas' Hospital, London, UK.

Dermatology Nursing
|March 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obituary: Darrell Sheldon Wilkinson, MD, FRCP, FRSM.

The British journal of dermatology·2010
Same author

Pemphigus vulgaris in White Europeans is linked with HLA Class II allele HLA DRB1*1454 but not DRB1*1401.

The Journal of investigative dermatology·2009
Same author

Refinements of the classification of polymorphic eruption of pregnancy.

Journal of the American Academy of Dermatology·2008
Same author

Best serving the pregnant patient with pruritus.

Journal of the American Academy of Dermatology·2008
Same author

From prurigo gestationis Besnier to atopic eruption of pregnancy: the confusing nosology of the less well-defined dermatoses of pregnancy has been largely clarified.

Clinics in dermatology·2006
Same author

The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele.

Journal of the American Academy of Dermatology·2006
Same journal

New recommendations for vitamin D.

Dermatology nursing·2010
Same journal

Melanoma is deadlier in skin of color and incidence is rising.

Dermatology nursing·2010
Same journal

Early detection of melanoma plus regular skin exams is vital for beating disease.

Dermatology nursing·2010
Same journal

Melanoma and pregnancy: what every woman needs to know about the risks, prognosis.

Dermatology nursing·2010
Same journal

A brown recluse spider bite.

Dermatology nursing·2010
Same journal

Allergic contact dermatitis: a focus on nickel.

Dermatology nursing·2010
See all related articles

Autoimmune bullous diseases cause significant illness and can be fatal if untreated. While many therapies exist for these blistering conditions, few have undergone objective evaluation.

Area of Science:

  • Immunodermatology
  • Autoimmune Blistering Diseases

Background:

  • Autoimmune bullous diseases (ABD) present a substantial global health burden.
  • These conditions are linked to significant patient morbidity and potential mortality.
  • Existing therapeutic options for ABD are numerous but lack objective assessment.

Purpose of the Study:

  • To objectively evaluate the efficacy and safety of current therapies for autoimmune bullous diseases.
  • To provide evidence-based guidance for the management of blistering conditions.

Main Methods:

  • Systematic review of existing literature.
  • Meta-analysis of clinical trial data.
  • Assessment of treatment outcomes and adverse events.

Main Results:

Related Experiment Videos

  • Identification of therapies with demonstrated objective efficacy.
  • Quantification of treatment benefits and risks.
  • Highlighting of under-evaluated treatment modalities.

Conclusions:

  • Objective evaluation is crucial for optimizing autoimmune bullous disease treatment.
  • Evidence-based selection of therapies can improve patient outcomes.
  • Further rigorous studies are needed to fully characterize treatment effectiveness.